Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, Maj-Linda B., Brownlow, Milene, Jimenez, Jeffy P., Lee, Daniel C., Pena, Gabriela, Dickey, Chad A., Gordon, Marcia N., Morgan, Dave·2013·Neurodegenerative Diseases

Cited by (1,606)

Items 101–200 of 1,606

  1. Defining imaging biomarker cut points for brain aging and Alzheimer's disease
    Jack, Clifford R., Wiste, Heather J., Weigand, Stephen D., Therneau, Terry M., Lowe, Val J., Knopman, David S., Gunter, Jeffrey L., Senjem, Matthew L., Jones, David T., Kantarci, Kejal et al. · 2017 · Alzheimer's & Dementia
  2. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
    Khandaker, Golam M, Cousins, Lesley, Deakin, Julia, Lennox, Belinda R, Yolken, Robert, Jones, Peter B · 2015 · The Lancet Psychiatry
  3. TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
    Amador‐Ortiz, Catalina, Lin, Wen‐Lang, Ahmed, Zeshan, Personett, David, Davies, Peter, Duara, Ranjan, Graff‐Radford, Neill R., Hutton, Michael L., Dickson, Dennis W. · 2007 · Annals of Neurology
  4. Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease
    Mahley, Robert W., Weisgraber, Karl H., Huang, Yadong · 2006 · Proceedings of the National Academy of Sciences
  5. Microglia in Alzheimer's disease
    Sarlus, Heela, Heneka, Michael T. · 2017 · Journal of Clinical Investigation
  6. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics
    Richard Nii Lante Lamptey, Bivek Chaulagain, Riddhi Trivedi, Avinash Gothwal, Buddhadev Layek, Jagdish Singh · 2022 · International Journal of Molecular Sciences
  7. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD
    Dickerson, B. C., Salat, D. H., Greve, D. N., Chua, E. F., Rand-Giovannetti, E., Rentz, D. M., Bertram, L., Mullin, K., Tanzi, R. E., Blacker, D. et al. · 2005 · Neurology
  8. Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice
    José J. Lucas, Félix Hernández, Pilar Gómez‐Ramos, María A. Morán, René Hen, Jesús Avila · 2001 · The EMBO Journal
  9. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
    Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T. et al. · 2017 · Scientific Reports
  10. Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease
    Lisa Mosconi · 2005 · European Journal of Nuclear Medicine and Molecular Imaging
  11. Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies
    Ciechanover, Aaron, Kwon, Yong Tae · 2015 · Experimental & Molecular Medicine
  12. Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau
    Caccamo, Antonella, Majumder, Smita, Richardson, Arlan, Strong, Randy, Oddo, Salvatore · 2010 · Journal of Biological Chemistry
  13. Structure-based classification of tauopathies
    Shi, Yang, Zhang, Wenjuan, Yang, Yang, Murzin, Alexey G., Falcon, Benjamin, Kotecha, Abhay, van Beers, Mike, Tarutani, Airi, Kametani, Fuyuki, Garringer, Holly J. et al. · 2021 · Nature
  14. Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain
    Carol A. Colton · 2009 · Journal of Neuroimmune Pharmacology
  15. Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
    Jin, Ming, Shepardson, Nina, Yang, Ting, Chen, Gang, Walsh, Dominic, Selkoe, Dennis J. · 2011 · Proceedings of the National Academy of Sciences
  16. ApoE Promotes the Proteolytic Degradation of Aβ
    Jiang, Qingguang, Lee, C.Y. Daniel, Mandrekar, Shweta, Wilkinson, Brandy, Cramer, Paige, Zelcer, Noam, Mann, Karen, Lamb, Bruce, Willson, Timothy M., Collins, Jon L. et al. · 2008 · Neuron
  17. The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
    Cline, Erika N., Bicca, Maíra Assunção, Viola, Kirsten L., Klein, William L. · 2018 · Journal of Alzheimer's Disease
  18. Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin
    Zenaro, Elena, Pietronigro, Enrica, Bianca, Vittorina Della, Piacentino, Gennj, Marongiu, Laura, Budui, Simona, Turano, Ermanna, Rossi, Barbara, Angiari, Stefano, Dusi, Silvia et al. · 2015 · Nature Medicine
  19. The genetic landscape of Alzheimer disease: clinical implications and perspectives
    Van Cauwenberghe, Caroline, Van Broeckhoven, Christine, Sleegers, Kristel · 2016 · Genetics in Medicine
  20. Microglial Phagocytosis of Live Neurons
    Brown, Guy C., Neher, Jonas J. · 2014 · Nature Reviews Neuroscience
  21. Mitochondria and Mitochondrial Cascades in Alzheimer’s disease
    Swerdlow, Russell H. · 2018 · Journal of Alzheimer’s Disease
  22. Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
    Kametani, Fuyuki, Hasegawa, Masato · 2018 · Frontiers in Neuroscience
  23. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer’s disease
    Georganopoulou, Dimitra G., Chang, Lei, Nam, Jwa-Min, Thaxton, C. Shad, Mufson, Elliott J., Klein, William L., Mirkin, Chad A. · 2005 · Proceedings of the National Academy of Sciences
  24. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage
    Maria Mańczak, Marcus J. Calkins, P. Hemachandra Reddy · 2011 · Human Molecular Genetics
  25. Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
    Gamblin, T. Chris, Chen, Feng, Zambrano, Angara, Abraha, Aida, Lagalwar, Sarita, Guillozet, Angela L., Lu, Meiling, Fu, Yifan, Garcia-Sierra, Francisco, LaPointe, Nichole et al. · 2003 · Proceedings of the National Academy of Sciences
  26. Neuronal activity enhances tau propagation and tau pathology in vivo
    Wu, Jessica W, Hussaini, S Abid, Bastille, Isle M, Rodriguez, Gustavo A, Mrejeru, Ana, Rilett, Kelly, Sanders, David W, Cook, Casey, Fu, Hongjun, Boonen, Rick A C M et al. · 2016 · Nature Neuroscience
  27. Alzheimer's disease: experimental models and reality
    Drummond, Eleanor, Wisniewski, Thomas · 2017 · Acta Neuropathologica
  28. Tau and neurodegenerative disease: the story so far
    Iqbal, Khalid, Liu, Fei, Gong, Cheng-Xin · 2016 · Nature Reviews Neurology
  29. Spreading of pathology in neurodegenerative diseases: a focus on human studies
    Brettschneider, Johannes, Tredici, Kelly Del, Lee, Virginia M.-Y., Trojanowski, John Q. · 2015 · Nature Reviews Neuroscience
  30. Stress granules and neurodegeneration
    Benjamin L. Wolozin, Pavel V. Ivanov · 2019 · Nature reviews. Neuroscience
  31. The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives
    Swerdlow, Russell H., Burns, Jeffrey M., Khan, Shaharyar M. · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  32. The Semantics of Microglia Activation: Neuroinflammation, Homeostasis, and Stress
    Woodburn, Samuel C., Bollinger, Justin L., Wohleb, Eric S. · 2021 · Journal of Neuroinflammation
  33. Liquid–liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau
    Ambadipudi, Susmitha, Biernat, Jacek, Riedel, Dietmar, Mandelkow, Eckhard, Zweckstetter, Markus · 2017 · Nature Communications
  34. Molecular mechanisms of protein aggregation from global fitting of kinetic models
    Georg Meisl, Julius B. Kirkegaard, Paolo Arosio, Thomas C. T. Michaels, Michele Vendruscolo, Christopher Martin Dobson, Sara Snogerup Linse, Tuomas P. J. Knowles · 2016 · Nature Protocols
  35. Molecular mechanisms of neurodegeneration in Alzheimer's disease
    Crews, L., Masliah, E. · 2010 · Human Molecular Genetics
  36. apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
    Deane, Rashid, Sagare, Abhay, Hamm, Katie, Parisi, Margaret, Lane, Steven, Finn, Mary Beth, Holtzman, David M., Zlokovic, Berislav V. · 2008 · Journal of Clinical Investigation
  37. Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration
    Cunningham, Colm, Wilcockson, David C., Campion, Suzanne, Lunnon, Katie, Perry, V. Hugh · 2005 · The Journal of Neuroscience
  38. The case for rejecting the amyloid cascade hypothesis
    Herrup, Karl · 2015 · Nature Neuroscience
  39. Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
    Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) investigators, Thijssen, Elisabeth H., La Joie, Renaud, Wolf, Amy, Strom, Amelia, Wang, Ping, Iaccarino, Leonardo, Bourakova, Viktoriya, Cobigo, Yann, Heuer, Hilary et al. · 2020 · Nature Medicine
  40. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress
    Stamer, K., Vogel, R., Thies, E., Mandelkow, E., Mandelkow, E.-M. · 2002 · The Journal of Cell Biology
  41. Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein
    Bridget Allen, Esther Ingram, Masaki Takao, Michael J. Smith, Ross Jakes, Kanwar Virdee, Hirotaka Yoshida, Max Holzer, Molly Craxton, Piers C. Emson et al. · 2002 · Journal of Neuroscience
  42. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics
    Karran, Eric, De Strooper, Bart · 2022 · Nature Reviews Drug Discovery
  43. Four distinct trajectories of tau deposition identified in Alzheimer’s disease
    the Alzheimer’s Disease Neuroimaging Initiative, Vogel, Jacob W., Young, Alexandra L., Oxtoby, Neil P., Smith, Ruben, Ossenkoppele, Rik, Strandberg, Olof T., La Joie, Renaud, Aksman, Leon M., Grothe, Michel J. et al. · 2021 · Nature Medicine
  44. The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
    Sengupta, Urmi, Nilson, Ashley N., Kayed, Rakez · 2016 · EBioMedicine
  45. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.
    Alonso, A C, Zaidi, T, Grundke-Iqbal, I, Iqbal, K · 1994 · Proceedings of the National Academy of Sciences
  46. Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation
    Lui, Hansen, Zhang, Jiasheng, Makinson, Stefanie R., Cahill, Michelle K., Kelley, Kevin W., Huang, Hsin-Yi, Shang, Yulei, Oldham, Michael C., Martens, Lauren Herl, Gao, Fuying et al. · 2016 · Cell
  47. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
    Robinson, John L, Lee, Edward B, Xie, Sharon X, Rennert, Lior, Suh, EunRan, Bredenberg, Colin, Caswell, Carrie, Van Deerlin, Vivianna M, Yan, Ning, Yousef, Ahmed et al. · 2018 · Brain
  48. The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
    Sperling, Reisa, Mormino, Elizabeth, Johnson, Keith · 2014 · Neuron
  49. History and progress of hypotheses and clinical trials for Alzheimer’s disease
    Liu, Pei-Pei, Xie, Yi, Meng, Xiao-Yan, Kang, Jian-Sheng · 2019 · Signal Transduction and Targeted Therapy
  50. Green tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice
    Rezai-Zadeh, Kavon, Shytle, Doug, Sun, Nan, Mori, Takashi, Hou, Huayan, Jeanniton, Deborah, Ehrhart, Jared, Townsend, Kirk, Zeng, Jin, Morgan, David et al. · 2005 · The Journal of Neuroscience
  51. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration <i>in vivo</i>
    Noble, Wendy, Planel, Emmanuel, Zehr, Cindy, Olm, Vicki, Meyerson, Jordana, Suleman, Farhana, Gaynor, Kate, Wang, Lili, LaFrancois, John, Feinstein, Boris et al. · 2005 · Proceedings of the National Academy of Sciences
  52. Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression
    W. Sue T. Griffin, Jin G. Sheng, M. Claire Royston, Steve Gentleman, J.E. McKenzie, David Ian Graham, G.W. Roberts, Robert Emil Mrak · 1998 · Brain Pathology
  53. Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
    Sara Bachiller, Itzia Jiménez-Ferrer, Agnes Paulus, Yiyi Yang, Maria Swanberg, Tomas Deierborg, Antonio Boza‐Serrano · 2018 · Frontiers in Cellular Neuroscience
  54. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model
    Calon, Frédéric, Lim, Giselle P., Yang, Fusheng, Morihara, Takashi, Teter, Bruce, Ubeda, Oliver, Rostaing, Phillippe, Triller, Antoine, Salem, Norman, Ashe, Karen H. et al. · 2004 · Neuron
  55. Intraneuronal Alzheimer Aβ42 Accumulates in Multivesicular Bodies and Is Associated with Synaptic Pathology
    Takahashi, Reisuke H., Milner, Teresa A., Li, Feng, Nam, Ellen E., Edgar, Mark A., Yamaguchi, Haruyasu, Beal, M. Flint, Xu, Huaxi, Greengard, Paul, Gouras, Gunnar K. · 2002 · The American Journal of Pathology
  56. New insights into atypical Alzheimer's disease in the era of biomarkers
    Graff-Radford, Jonathan, Yong, Keir X X, Apostolova, Liana G, Bouwman, Femke H, Carrillo, Maria, Dickerson, Bradford C, Rabinovici, Gil D, Schott, Jonathan M, Jones, David T, Murray, Melissa E · 2021 · The Lancet Neurology
  57. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
    Goran Šimić, Mirjana Babić Leko, Selina Wray, Charles R. Harrington, Ivana Delalle, Nataša Jovanov Milošević, Danira Bažadona, Luc Buée, Rohan de Silva, Giuseppe Di Giovanni et al. · 2016 · Biomolecules
  58. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
    Perrin, Richard J., Fagan, Anne M., Holtzman, David M. · 2009 · Nature
  59. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)
    Ramsden, Martin, Kotilinek, Linda, Forster, Colleen, Paulson, Jennifer, McGowan, Eileen, SantaCruz, Karen, Guimaraes, Aaron, Yue, Mei, Lewis, Jada, Carlson, George et al. · 2005 · The Journal of Neuroscience
  60. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
    Jacobsen, J. Steven, Wu, Chi-Cheng, Redwine, Jeffrey M., Comery, Thomas A., Arias, Robert, Bowlby, Mark, Martone, Robert, Morrison, John H., Pangalos, Menelas N., Reinhart, Peter H. et al. · 2006 · Proceedings of the National Academy of Sciences
  61. Cytokine networks in neuroinflammation
    Burkhard Becher, Sabine Spath, Joan M. Goverman · 2016 · Nature reviews. Immunology
  62. NFκB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer’s Disease
    Lian, Hong, Yang, Li, Cole, Allysa, Sun, Lu, Chiang, Angie C.-A., Fowler, Stephanie W., Shim, David J., Rodriguez-Rivera, Jennifer, Taglialatela, Giulio, Jankowsky, Joanna L. et al. · 2015 · Neuron
  63. Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease
    Kitazawa, Masashi, Oddo, Salvatore, Yamasaki, Tritia R., Green, Kim N., LaFerla, Frank M. · 2005 · The Journal of Neuroscience
  64. Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology
    Spangenberg, Elizabeth E., Lee, Rafael J., Najafi, Allison R., Rice, Rachel A., Elmore, Monica R. P., Blurton-Jones, Mathew, West, Brian L., Green, Kim N. · 2016 · Brain
  65. The β-Secretase BACE1 in Alzheimer’s Disease
    Hampel, Harald, Vassar, Robert, De Strooper, Bart, Hardy, John, Willem, Michael, Singh, Neeraj, Zhou, John, Yan, Riqiang, Vanmechelen, Eugeen, De Vos, Ann et al. · 2021 · Biological Psychiatry
  66. Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
    Erik S. Musiek, David M. Holtzman · 2015 · Nature Neuroscience
  67. Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons
    Ravi Rajmohan, P. Hemachandra Reddy · 2016 · Journal of Alzheimer s Disease
  68. Interaction between Aβ and Tau in the Pathogenesis of Alzheimer’s Disease
    Zhang, Huiqin, Wei, Wei, Zhao, Ming, Ma, Lina, Jiang, Xuefan, Pei, Hui, Cao, Yu, Li, Hao · 2021 · International Journal of Biological Sciences
  69. Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease
    Wesseling, Hendrik, Mair, Waltraud, Kumar, Mukesh, Schlaffner, Christoph N., Tang, Shaojun, Beerepoot, Pieter, Fatou, Benoit, Guise, Amanda J., Cheng, Long, Takeda, Shuko et al. · 2020 · Cell
  70. Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis
    Phuong Hoang Nguyen, Ayyalusamy Ramamoorthy, Bikash Ranjan Sahoo, Jie Zheng, Peter Faller, John E. Straub, Laura Domı́nguez, Joan‐Emma Shea, Nikolay V. Dokholyan, Alfonso De Simone et al. · 2021 · Chemical Reviews
  71. The genetic epidemiology of neurodegenerative disease
    Bertram, L. · 2005 · Journal of Clinical Investigation
  72. Immune activation in brain aging and neurodegeneration: too much or too little?
    Lucin, Kurt M., Wyss-Coray, Tony · 2009 · Neuron
  73. Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System
    Bell, Robert D, Sagare, Abhay P, Friedman, Alan E, Bedi, Gurrinder S, Holtzman, David M, Deane, Rashid, Zlokovic, Berislav V · 2007 · Journal of Cerebral Blood Flow &amp; Metabolism
  74. Integrating neuroimmune systems in the neurobiology of depression
    Wohleb, Eric S., Franklin, Tina, Iwata, Masaaki, Duman, Ronald S. · 2016 · Nature Reviews Neuroscience
  75. Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy
    Iba, Michiyo, Guo, Jing L., McBride, Jennifer D., Zhang, Bin, Trojanowski, John Q., Lee, Virginia M.-Y. · 2013 · The Journal of Neuroscience
  76. Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model
    Ian F. Harrison, Ozama Ismail, Asif Machhada, Niall C. Colgan, Yolanda Ohene, Payam Nahavandi, Zeshan Ahmed, Alice Fisher, Soraya Meftah, Tracey K. Murray et al. · 2020 · Brain
  77. Role of Microglia in Neurotrauma
    Loane, David J., Byrnes, Kimberly R. · 2010 · Neurotherapeutics
  78. Phagocytosis of Microglia in the Central Nervous System Diseases
    Ruying Fu, Qingyu Shen, Pengfei Xu, Jin Jun Luo, Yamei Tang · 2014 · Molecular Neurobiology
  79. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
    the Dominantly Inherited Alzheimer Network, Barthélemy, Nicolas R., Li, Yan, Joseph-Mathurin, Nelly, Gordon, Brian A., Hassenstab, Jason, Benzinger, Tammie. L. S., Buckles, Virginia, Fagan, Anne M., Perrin, Richard J. et al. · 2020 · Nature Medicine
  80. Microglia contact induces synapse formation in developing somatosensory cortex
    Miyamoto, Akiko, Wake, Hiroaki, Ishikawa, Ayako Wendy, Eto, Kei, Shibata, Keisuke, Murakoshi, Hideji, Koizumi, Schuichi, Moorhouse, Andrew J., Yoshimura, Yumiko, Nabekura, Junichi · 2016 · Nature Communications
  81. Alzheimer’s Disease: Past, Present, and Future
    Bondi, Mark W., Edmonds, Emily C., Salmon, David P. · 2017 · Journal of the International Neuropsychological Society
  82. Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
    Cheng‐Xin Gong, Khalid Iqbal · 2008 · Current Medicinal Chemistry
  83. Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
    He, Zhuohao, Guo, Jing L, McBride, Jennifer D, Narasimhan, Sneha, Kim, Hyesung, Changolkar, Lakshmi, Zhang, Bin, Gathagan, Ronald J, Yue, Cuiyong, Dengler, Christopher et al. · 2018 · Nature Medicine
  84. The high-affinity HSP90–CHIP complex recognizes and selectively degrades phosphorylated tau client proteins
    Dickey, Chad A., Kamal, Adeela, Lundgren, Karen, Klosak, Natalia, Bailey, Rachel M., Dunmore, Judith, Ash, Peter, Shoraka, Sareh, Zlatkovic, Jelena, Eckman, Christopher B. et al. · 2007 · Journal of Clinical Investigation
  85. Physiological release of endogenous tau is stimulated by neuronal activity
    Pooler, Amy M, Phillips, Emma C, Lau, Dawn H W, Noble, Wendy, Hanger, Diane P · 2013 · The EMBO Reports
  86. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
    Postina, Rolf, Schroeder, Anja, Dewachter, Ilse, Bohl, Juergen, Schmitt, Ulrich, Kojro, Elzbieta, Prinzen, Claudia, Endres, Kristina, Hiemke, Christoph, Blessing, Manfred et al. · 2004 · Journal of Clinical Investigation
  87. Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior
    Luczynski, Pauline, McVey Neufeld, Karen-Anne, Oriach, Clara Seira, Clarke, Gerard, Dinan, Timothy G., Cryan, John F. · 2016 · International Journal of Neuropsychopharmacology
  88. Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression
    Bai, Bing, Wang, Xusheng, Li, Yuxin, Chen, Ping-Chung, Yu, Kaiwen, Dey, Kaushik Kumar, Yarbro, Jay M., Han, Xian, Lutz, Brianna M., Rao, Shuquan et al. · 2020 · Neuron
  89. Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
    Viola, Kirsten L., Klein, William L. · 2015 · Acta Neuropathologica
  90. Tau PET imaging in neurodegenerative tauopathies—still a challenge
    Leuzy, Antoine, Chiotis, Konstantinos, Lemoine, Laetitia, Gillberg, Per-Göran, Almkvist, Ove, Rodriguez-Vieitez, Elena, Nordberg, Agneta · 2019 · Molecular Psychiatry
  91. The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
    Schulz-Schaeffer, Walter J. · 2010 · Acta Neuropathologica
  92. Protein transmission in neurodegenerative disease
    Peng, Chao, Trojanowski, John Q., Lee, Virginia M.-Y. · 2020 · Nature Reviews Neurology
  93. Glucocorticoids increase amyloid-β and tau pathology in a mouse model of alzheimer’s disease
    Green, Kim N., Billings, Lauren M., Roozendaal, Benno, McGaugh, James L., LaFerla, Frank M. · 2006 · The Journal of Neuroscience
  94. Is Alzheimer’s disease a type 3 diabetes? A critical appraisal
    Kandimalla, Ramesh, Thirumala, Vani, Reddy, P. Hemachandra · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  95. Mitochondria at the neuronal presynapse in health and disease
    Michael J. Devine, Josef T. Kittler · 2018 · Nature reviews. Neuroscience
  96. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis
    Holtman, Inge R, Raj, Divya D, Miller, Jeremy A, Schaafsma, Wandert, Yin, Zhuoran, Brouwer, Nieske, Wes, Paul D, Möller, Thomas, Orre, Marie, Kamphuis, Willem et al. · 2015 · Acta Neuropathologica Communications
  97. Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers
    Townsend, Matthew, Shankar, Ganesh M., Mehta, Tapan, Walsh, Dominic M., Selkoe, Dennis J. · 2006 · The Journal of Physiology
  98. Emerging Roles of Exosomes in Normal and Pathological Conditions: New Insights for Diagnosis and Therapeutic Applications
    Julieta De Toro, Leticia Herschlik, Claudia Waldner, Claudia Mongini · 2015 · Frontiers in Immunology
  99. Amyloid β-Protein Assembly and Alzheimer Disease
    Robin Roychaudhuri, Mingfeng Yang, Minako M. Hoshi, David B. Teplow · 2008 · Journal of Biological Chemistry
  100. Validating novel tau positron emission tomography tracer <scp>[F‐18]‐AV‐1451 (T807)</scp> on postmortem brain tissue
    Marquié, Marta, Normandin, Marc D., Vanderburg, Charles R., Costantino, Isabel M., Bien, Elizabeth A., Rycyna, Lisa G., Klunk, William E., Mathis, Chester A., Ikonomovic, Milos D., Debnath, Manik L. et al. · 2015 · Annals of Neurology